Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- 36C24823N0285
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI ZL79MXYVNDM1 Part of Jubilant Draximage Radiopharmacies, Inc.
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,491,862
Award facts
- Contract value 100% obligated
- $1,491,861.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$222,253 | |
| Funding Only Action | -$29,001 | |
| Supplemental Agreement for work within scope | $62,350 | |
| Supplemental Agreement for work within scope | $433,518 | |
| Original award | $1,247,248 |
About this award
Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a delivery order valued at $1.49 million on January 5, 2023, for the supply of radiopharmaceuticals to the Veterans Integrated Service Network 8 (VISN 8), a regional healthcare network within the Department of Veterans Affairs. The contract, which was not set aside, carries a firm fixed-price structure with an ultimate completion date of September 30, 2023, and is to be performed in Norcross, Georgia. This award represents a decrease in funding from the previous fiscal year and covers the provision of specialized nuclear medicine products essential for diagnostic imaging, positron emission tomography (PET) scans, and cancer treatment diagnostics at VA medical facilities.
As a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma serves as a critical supplier of radiopharmaceutical products to the VA and other federal healthcare agencies. The company operates under a broader Indefinite Delivery Contract with VISN 8 valued at approximately $39.8 million, from which this delivery order was issued. Jubilant Radiopharma's product portfolio includes specialized medical isotopes such as technetium-99m, iodine I-123, Gallium-68 Dotatate, and other diagnostic agents that support nuclear medicine procedures across VA facilities nationwide, reinforcing the company's established role as a primary supplier within the VA's healthcare procurement strategy.
Quick answers
Who was awarded contract 36C24823N0285?
36C24823N0285 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on January 5, 2023.
How much is contract 36C24823N0285 worth?
The government has obligated $1,491,862 on 36C24823N0285.
Is contract 36C24823N0285 an order under another contract?
Yes. 36C24823N0285 is a delivery order under 36C24823D0050, an indefinite delivery contract.
Was contract 36C24823N0285 competed?
The extent of competition for 36C24823N0285 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award